Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

Surgery and appointment information – Learn more

For the safety of our patients and caregivers, we have expanded and changed how we deliver care to reduce the spread of COVID-19.

Depending on your medical needs, your appointments could take place in-person, by phone or by video. There may be times when an appointment or procedure may be rescheduled. In which case, we will contact you to let you know. Rest assured, all urgent needs will be addressed promptly.

Existing ChristianaCare patients can request an appointment using their patient portal account.

Visitor restrictions are still in place for your protection. Please refer to our visitor policy for more details.

Our operating rooms are now accommodating elective procedures.

As an added safety measure, all patients will be screened for COVID-19. If needed, your doctor will order a COVID-19 test to be performed at a ChristianaCare laboratory three to five days before your procedure.

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

Surgery and appointment information – Learn more

For the safety of our patients and caregivers, we have expanded and changed how we deliver care to reduce the spread of COVID-19.

Depending on your medical needs, your appointments could take place in-person, by phone or by video. There may be times when an appointment or procedure may be rescheduled. In which case, we will contact you to let you know. Rest assured, all urgent needs will be addressed promptly.

Existing ChristianaCare patients can request an appointment using their patient portal account.

Visitor restrictions are still in place for your protection. Please refer to our visitor policy for more details.

Our operating rooms are now accommodating elective procedures.

As an added safety measure, all patients will be screened for COVID-19. If needed, your doctor will order a COVID-19 test to be performed at a ChristianaCare laboratory three to five days before your procedure.

Helen F. Graham Cancer Center
& Research Institute

CyberKnife

The CyberKnife Robotic Radiosurgery System is a noninvasive alternative to surgery for the treatment of tumors anywhere in the body—with fewer side effects. Cyberknife treatment delivers very high doses of radiation to tumors with extreme accuracy. There is no anesthesia, no pain and minimal recovery time. It’s like having an X-ray; you don’t feel anything. In fact, in most cases, patients can return to normal activity the next day.

Delaware’s most advanced radiosurgery system

Unlike traditional radiosurgery systems that can only treat tumors in the skull, Cyberknife can treat tumors anywhere, including the lung, pancreas, liver, spine and prostate. The system’s advanced maneuverability offers complete access and coverage for any tumor size or shape, even in difficult-to-reach areas. This means maximal radiation doses can be delivered for the greatest benefit with minimal damage to surrounding healthy tissues and organs.

SpaceOAR

For men receiving prostate cancer radiation therapy, the Cyberknife team is introducing the use of SpaceOAR (Organs at Risk) hydrogels to protect the rectum from injury and thereby improve outcomes. We are the only center in Delaware to introduce this advanced protection for prostate cancer therapy.

The CyberKnife at ChristianaCare is the first and only CyberKnife in Delaware and one of only a few in the Mid-Atlantic region. Here are just a few of its advantages:

  • Real-time tracking: We can continuously track the tumor position, detect the tumor’s location and make adjustments for tumor and patient movement throughout treatment sessions.
  • Pinpoint precision: The CyberKnife System delivers high-dose radiation with sub-millimeter accuracy (within the width of a hair), minimizing damage to surrounding healthy tissue accuracy.
  • Painless and noninvasive: The CyberKnife is painless and requires no anesthesia and no surgical incisions. It virtually eliminates the risk of complications such as infections, hemorrhage, and the loss of hearing or feeling associated with traditional surgery. It’s a pain-free, noninvasive alternative for patients, including those diagnosed with previously inoperable or surgically complex tumors, or for patients who are looking for an alternative to surgery.
  • No recovery time: Compared to traditional open surgery, CyberKnife treatments are performed on an outpatient basis, eliminating overnight hospital stays.
  • Superior comfort: Patients experience improved comfort due to the system’s frameless design, which eliminates the pain and inconvenience associated with the head or body frame used to immobilize patients in traditional radiosurgery.
  • Convenience: With an advanced planning system, a patient’s treatment setup can be scheduled at the patient’s convenience, and patients can be treated in as few as one to five visits.
  • Flexibility: Offers maneuverability and versatility that is unsurpassed by traditional radiation systems. By delivering radiation beams from virtually unlimited positions, the CyberKnife System can treat tumors anywhere in the body—from any angle—including the brain, spine, lung, liver, pancreas and prostate.

Cyberknife, ChristianaCare Helen F. Graham Cancer Center
4701 Ogletown-Stanton Road, Newark, DE 19713 directions
302-623-4836